[1] PRYSTOWSKY E N,PADANILAM B J,FOGEL R I.Treatment of Atrial Fibrillation[J].JAMA,2015,314(3):278-288.
[2] BORIANI G,LAROCHE C,DIEMBERGER I,et al.Asymptomatic atrial fibrillation:clinical correlates,management,and outcomes in the EORP-AF Pilot General Registry[J].Am J Med,2015,128(5):509-518.
[3] YUAN C T,LI X X,CHENG Q J,et al.MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1[J].Int J Clin Exp Pathol,2015,8(12):15527-15536.
[4] RANGANATHAN P,JAYAKUMAR C,TANG Y,et al.microRNA-150 deletion in mice protects kidney from myocardial infarction-induced acute kidney injury[J].Am J Physiol Renal Physiol,2015,309(6):F551-558.
[5] MOHR A M,MOTT J L.Overview of microRNA biology[J].Semin Liver Dis,2015,35(1):3-11.
[6] HAYES J,PERUZZI P P,LAWLER S.MicroRNAs in cancer:biomarkers,functions and therapy[J].Trends Mol Med,2014,20(8):460-469.
[7] SUN J S,ZHANG X L,YANG Y J,et al.Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells[J].Oncol Lett,2015,10(2):835-840.
[8] 杨雅静,李利廷,于卫芳,等.结直肠癌组织中miR-150表达及其对癌细胞增殖的影响[J].山东医药,2016,56(2):5-7.
[9] YIN Q W,SUN X F,YANG G T,et al.Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer[J].Int J Clin Exp Pathol,2015,8(1):842-846.
[10] 于卫芳,翟从劼,樊智彬,等.miR-150和miR-134在结直肠癌及腺瘤中的表达[J].中国普通外科杂志,2014,23(10):1349-1354.
[11] WANG F,REN X,ZHANG X.Role of microRNA-150 in solid tumors[J].Oncol Lett,2015,10(1):11-16.
[12] LI X,CHEN L,WANG W,et al.microRNA-150 inhibits cell invasion and migration and is downregulated in human osteosarcoma[J].Cytogenet Genome Res,2015,146(2):124-135.
[13] DENG P,CHEN L,LIU Z,et al.microRNA-150 inhibits the activation of cardiac fibroblasts by regulating c-Myb[J].Cell Physiol Biochem,2016,38(6):2103-2122.
[14] 崔云霞,毕慧梅,闫俊霞,等.microRNA-150在糖尿病心肌纤维化中的变化及对胶原Ⅰ的影响[J].中国卫生检验杂志,2012,22(2):208-210.
[15] 周小翠,汪涛,李恩.miR-150通过靶基因c-Myb改善心肌梗死后心肌纤维化[J].实用医学杂志,2017,33(7):1078-1082.
[16] HEINDRYCKX F,BINET F,PONTICOS M,et al.Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing[J].EMBO Mol Med,2016,8(7):729-744.
[17] SUI X,WEI H,WANG D.Novel mechanism of cardiac protection by valsartan:synergetic roles of TGF-β1 and HIF-1α in Ang Ⅱ-mediated fibrosis after myocardial infarction[J].J Cell Mol Med,2015,19(8):1773-1782.
[18] LI Z,BI X,WANG M,et al.Inhibition of farnesyl pyrophosphate synthase prevents angiotensin Ⅱ-induced cardiac fibrosis in vitro[J].Clin Exp Immunol,2014,176(3):429-437.
[19] 王爱波.急性心肌梗死并发心房颤动的相关因素及近期预后分析[J].现代医学,2016,44(8):1104-1106.
[20] WANG X,LV H,GU Y,et al.Protective effect of lycopene on cardiac function and myocardial fibrosis after acute myocardial infarction in rats via the modulation of p38 and MMP-9[J].J Mol Histol,2014,5(1):113-120. |